The New York Center for the Prevention of Heart Disease (212-717-0066) has expanded its preventative cardiology services, now offering advanced AI-powered diagnostic testing with the Cleerly and Heartflow platforms.
-- The NY Center for the Prevention of Heart Disease has announced additional diagnostic services as part of its preventative cardiology treatments, with AI-powered technologies like Cleerly and Heartflow tests now available to patients. The services are being offered alongside the clinic’s coronary CT angiograms and advanced lipid testing by Boston Heart Diagnostic Labs, which can be combined to provide patients with an accurate assessment of their risks of heart disease and stroke.
For more information, please visit https://www.thenyheartcenter.com/
According to one survey by the National Center for Health Statistics, 919,032 Americans died from cardiovascular disease in 2023, an equivalent of 1 in 3 people. Despite being one of the leading causes of death in the United States, heart disease often goes undiagnosed, with estimates from Harvard Medical School suggesting that up to 60% of individuals may experience an asymptomatic heart attack in their lifetime.
Dr. Bradley Radwaner, founder and medical director of The NY Center for the Prevention of Heart Disease, adds that standard cholesterol testing may fail to detect symptoms of heart disease in over 50% of individuals. For this reason, the clinic focuses on preventative cardiology with advanced diagnostic tools like the Cleerly analysis, which uses imaging and artificial intelligence to provide a detailed assessment of an individual’s heart health.
Using AI technology and coronary CT angiography, the Cleerly test creates detailed 3D maps of the heart, allowing cardiologists to identify the type, location, and amount of plaque in the patient’s coronary arteries. Because the tool provides comprehensive information on the characteristics of an individual’s plaque buildup, The NY Center for the Prevention of Heart Disease says it can be used to detect the warning signs of cardiovascular disease even at its earliest stages.
Moreover, the clinic combines Cleerly diagnostic tools with Heartflow AI-powered analytical tools and advanced lipid testing provided by Boston Heart Diagnostic Labs. Dr. Radwaner and his team use this information to accurately determine the patient’s risk of heart attack or stroke.
Once Dr. Radwaner has reviewed the patient’s results, he develops individualized prevention plans, which may include diet changes, exercise routines, cholesterol reduction medications, and other interventions that are recommended based on the patient’s unique risk factors.
More information is available at https://www.thenyheartcenter.com/
Contact Info:
Name: Dr Radwaner
Email: Send Email
Organization: The NY Center for the Prevention of Heart Disease
Address: 136 East 57th Street, Suite 1001 Suite 1001, New York, NY 10022, United States
Phone: +1-212-717-0666
Website: https://www.thenyheartcenter.com/
Source: PressCable
Release ID: 89205402
In the event of detecting errors, concerns, or irregularities in the content shared in this press release that require attention or if there is a need for a press release takedown, we kindly request that you inform us promptly by contacting [email protected] (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our dedicated team will promptly address your feedback within 8 hours and take necessary actions to resolve any identified issues diligently or guide you through the removal process. Providing accurate and dependable information is our utmost priority.
